nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—FDPS—osteoporosis	0.139	1	CbGaD
Ibandronate—Diphosphonates—Etidronic acid—osteoporosis	0.0691	0.25	CiPCiCtD
Ibandronate—Diphosphonates—Risedronate—osteoporosis	0.0691	0.25	CiPCiCtD
Ibandronate—Diphosphonates—Alendronate—osteoporosis	0.0691	0.25	CiPCiCtD
Ibandronate—Diphosphonates—Pamidronate—osteoporosis	0.0691	0.25	CiPCiCtD
Ibandronate—FDPS—Pamidronate—osteoporosis	0.0584	0.361	CbGbCtD
Ibandronate—Zoledronate—osteoporosis	0.0474	0.205	CrCtD
Ibandronate—Etidronic acid—osteoporosis	0.0474	0.205	CrCtD
Ibandronate—Risedronate—osteoporosis	0.0474	0.205	CrCtD
Ibandronate—Pamidronate—osteoporosis	0.0446	0.193	CrCtD
Ibandronate—Alendronate—osteoporosis	0.0446	0.193	CrCtD
Ibandronate—FDPS—Risedronate—osteoporosis	0.0442	0.273	CbGbCtD
Ibandronate—FDPS—Alendronate—osteoporosis	0.0307	0.19	CbGbCtD
Ibandronate—FDPS—Zoledronate—osteoporosis	0.0285	0.176	CbGbCtD
Ibandronate—Zoledronate—Risedronate—osteoporosis	0.00795	0.0537	CrCrCtD
Ibandronate—Risedronate—Etidronic acid—osteoporosis	0.00795	0.0537	CrCrCtD
Ibandronate—Risedronate—Zoledronate—osteoporosis	0.00795	0.0537	CrCrCtD
Ibandronate—Etidronic acid—Zoledronate—osteoporosis	0.00795	0.0537	CrCrCtD
Ibandronate—Zoledronate—Etidronic acid—osteoporosis	0.00795	0.0537	CrCrCtD
Ibandronate—Etidronic acid—Risedronate—osteoporosis	0.00795	0.0537	CrCrCtD
Ibandronate—Risedronate—Alendronate—osteoporosis	0.00747	0.0505	CrCrCtD
Ibandronate—Zoledronate—Alendronate—osteoporosis	0.00747	0.0505	CrCrCtD
Ibandronate—Etidronic acid—Pamidronate—osteoporosis	0.00747	0.0505	CrCrCtD
Ibandronate—Risedronate—Pamidronate—osteoporosis	0.00747	0.0505	CrCrCtD
Ibandronate—Etidronic acid—Alendronate—osteoporosis	0.00747	0.0505	CrCrCtD
Ibandronate—Zoledronate—Pamidronate—osteoporosis	0.00747	0.0505	CrCrCtD
Ibandronate—Alendronate—Zoledronate—osteoporosis	0.00703	0.0475	CrCrCtD
Ibandronate—Pamidronate—Zoledronate—osteoporosis	0.00703	0.0475	CrCrCtD
Ibandronate—Alendronate—Etidronic acid—osteoporosis	0.00703	0.0475	CrCrCtD
Ibandronate—Alendronate—Risedronate—osteoporosis	0.00703	0.0475	CrCrCtD
Ibandronate—Pamidronate—Risedronate—osteoporosis	0.00703	0.0475	CrCrCtD
Ibandronate—Pamidronate—Etidronic acid—osteoporosis	0.00703	0.0475	CrCrCtD
Ibandronate—Alendronate—Pamidronate—osteoporosis	0.00661	0.0447	CrCrCtD
Ibandronate—Pamidronate—Alendronate—osteoporosis	0.00661	0.0447	CrCrCtD
Ibandronate—FDPS—jaw skeleton—osteoporosis	0.00369	0.514	CbGeAlD
Ibandronate—FDPS—periosteum—osteoporosis	0.00278	0.388	CbGeAlD
Ibandronate—Pamidronate—FDPS—osteoporosis	0.000407	0.334	CrCbGaD
Ibandronate—FDPS—uterus—osteoporosis	0.000381	0.0531	CbGeAlD
Ibandronate—Risedronate—FDPS—osteoporosis	0.000328	0.269	CrCbGaD
Ibandronate—FDPS—bone marrow—osteoporosis	0.000323	0.045	CbGeAlD
Ibandronate—Alendronate—FDPS—osteoporosis	0.000214	0.175	CrCbGaD
Ibandronate—Zoledronate—FDPS—osteoporosis	0.000212	0.173	CrCbGaD
Ibandronate—Zoledronate—CA2—osteoporosis	5.84e-05	0.0479	CrCbGaD
Ibandronate—Infection—Pamidronate—osteoporosis	1.32e-05	0.000379	CcSEcCtD
Ibandronate—Urticaria—Calcitriol—osteoporosis	1.32e-05	0.000379	CcSEcCtD
Ibandronate—Haemorrhage—Estradiol—osteoporosis	1.32e-05	0.000378	CcSEcCtD
Ibandronate—Palpitations—Zoledronate—osteoporosis	1.31e-05	0.000378	CcSEcCtD
Ibandronate—Body temperature increased—Calcitriol—osteoporosis	1.31e-05	0.000377	CcSEcCtD
Ibandronate—Abdominal pain—Calcitriol—osteoporosis	1.31e-05	0.000377	CcSEcCtD
Ibandronate—Angioedema—Conjugated Estrogens—osteoporosis	1.31e-05	0.000376	CcSEcCtD
Ibandronate—Shock—Pamidronate—osteoporosis	1.31e-05	0.000376	CcSEcCtD
Ibandronate—Pharyngitis—Estradiol—osteoporosis	1.31e-05	0.000376	CcSEcCtD
Ibandronate—Hypersensitivity—Estropipate—osteoporosis	1.3e-05	0.000375	CcSEcCtD
Ibandronate—Nervous system disorder—Pamidronate—osteoporosis	1.3e-05	0.000375	CcSEcCtD
Ibandronate—Urinary tract disorder—Estradiol—osteoporosis	1.3e-05	0.000374	CcSEcCtD
Ibandronate—Vomiting—Etidronic acid—osteoporosis	1.3e-05	0.000374	CcSEcCtD
Ibandronate—Oedema peripheral—Estradiol—osteoporosis	1.3e-05	0.000373	CcSEcCtD
Ibandronate—Connective tissue disorder—Estradiol—osteoporosis	1.29e-05	0.000372	CcSEcCtD
Ibandronate—Urethral disorder—Estradiol—osteoporosis	1.29e-05	0.000371	CcSEcCtD
Ibandronate—Rash—Etidronic acid—osteoporosis	1.29e-05	0.000371	CcSEcCtD
Ibandronate—Dermatitis—Etidronic acid—osteoporosis	1.29e-05	0.00037	CcSEcCtD
Ibandronate—Vertigo—Conjugated Estrogens—osteoporosis	1.29e-05	0.00037	CcSEcCtD
Ibandronate—Hyperhidrosis—Pamidronate—osteoporosis	1.28e-05	0.000369	CcSEcCtD
Ibandronate—Hypertension—Zoledronate—osteoporosis	1.28e-05	0.000369	CcSEcCtD
Ibandronate—Hypersensitivity—Alendronate—osteoporosis	1.28e-05	0.000369	CcSEcCtD
Ibandronate—Headache—Etidronic acid—osteoporosis	1.28e-05	0.000368	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Risedronate—osteoporosis	1.27e-05	0.000366	CcSEcCtD
Ibandronate—Asthenia—Estropipate—osteoporosis	1.27e-05	0.000365	CcSEcCtD
Ibandronate—Myalgia—Zoledronate—osteoporosis	1.27e-05	0.000364	CcSEcCtD
Ibandronate—Arthralgia—Zoledronate—osteoporosis	1.27e-05	0.000364	CcSEcCtD
Ibandronate—Chest pain—Zoledronate—osteoporosis	1.27e-05	0.000364	CcSEcCtD
Ibandronate—Palpitations—Conjugated Estrogens—osteoporosis	1.26e-05	0.000364	CcSEcCtD
Ibandronate—Insomnia—Risedronate—osteoporosis	1.26e-05	0.000363	CcSEcCtD
Ibandronate—Anxiety—Zoledronate—osteoporosis	1.26e-05	0.000363	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	1.26e-05	0.000361	CcSEcCtD
Ibandronate—Paraesthesia—Risedronate—osteoporosis	1.25e-05	0.000361	CcSEcCtD
Ibandronate—Pruritus—Estropipate—osteoporosis	1.25e-05	0.00036	CcSEcCtD
Ibandronate—Discomfort—Zoledronate—osteoporosis	1.25e-05	0.00036	CcSEcCtD
Ibandronate—Asthenia—Alendronate—osteoporosis	1.25e-05	0.000359	CcSEcCtD
Ibandronate—Dry mouth—Zoledronate—osteoporosis	1.24e-05	0.000356	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	1.24e-05	0.000356	CcSEcCtD
Ibandronate—Fatigue—Ethinyl Estradiol—osteoporosis	1.24e-05	0.000355	CcSEcCtD
Ibandronate—Pruritus—Alendronate—osteoporosis	1.23e-05	0.000354	CcSEcCtD
Ibandronate—Dyspepsia—Risedronate—osteoporosis	1.23e-05	0.000354	CcSEcCtD
Ibandronate—Eye disorder—Estradiol—osteoporosis	1.23e-05	0.000354	CcSEcCtD
Ibandronate—Constipation—Ethinyl Estradiol—osteoporosis	1.23e-05	0.000352	CcSEcCtD
Ibandronate—Hypersensitivity—Calcitriol—osteoporosis	1.22e-05	0.000352	CcSEcCtD
Ibandronate—Cardiac disorder—Estradiol—osteoporosis	1.22e-05	0.000351	CcSEcCtD
Ibandronate—Chest pain—Conjugated Estrogens—osteoporosis	1.22e-05	0.00035	CcSEcCtD
Ibandronate—Myalgia—Conjugated Estrogens—osteoporosis	1.22e-05	0.00035	CcSEcCtD
Ibandronate—Arthralgia—Conjugated Estrogens—osteoporosis	1.22e-05	0.00035	CcSEcCtD
Ibandronate—Anxiety—Conjugated Estrogens—osteoporosis	1.21e-05	0.000349	CcSEcCtD
Ibandronate—Nausea—Etidronic acid—osteoporosis	1.21e-05	0.000349	CcSEcCtD
Ibandronate—Anaphylactic shock—Zoledronate—osteoporosis	1.21e-05	0.000349	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	1.21e-05	0.000348	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Pamidronate—osteoporosis	1.21e-05	0.000348	CcSEcCtD
Ibandronate—Diarrhoea—Estropipate—osteoporosis	1.21e-05	0.000348	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Risedronate—osteoporosis	1.21e-05	0.000347	CcSEcCtD
Ibandronate—Infection—Zoledronate—osteoporosis	1.2e-05	0.000347	CcSEcCtD
Ibandronate—Fatigue—Risedronate—osteoporosis	1.2e-05	0.000346	CcSEcCtD
Ibandronate—Insomnia—Pamidronate—osteoporosis	1.2e-05	0.000345	CcSEcCtD
Ibandronate—Pain—Risedronate—osteoporosis	1.19e-05	0.000344	CcSEcCtD
Ibandronate—Constipation—Risedronate—osteoporosis	1.19e-05	0.000344	CcSEcCtD
Ibandronate—Angiopathy—Estradiol—osteoporosis	1.19e-05	0.000343	CcSEcCtD
Ibandronate—Shock—Zoledronate—osteoporosis	1.19e-05	0.000343	CcSEcCtD
Ibandronate—Paraesthesia—Pamidronate—osteoporosis	1.19e-05	0.000343	CcSEcCtD
Ibandronate—Diarrhoea—Alendronate—osteoporosis	1.19e-05	0.000343	CcSEcCtD
Ibandronate—Asthenia—Calcitriol—osteoporosis	1.19e-05	0.000342	CcSEcCtD
Ibandronate—Nervous system disorder—Zoledronate—osteoporosis	1.19e-05	0.000342	CcSEcCtD
Ibandronate—Immune system disorder—Estradiol—osteoporosis	1.19e-05	0.000342	CcSEcCtD
Ibandronate—Mediastinal disorder—Estradiol—osteoporosis	1.19e-05	0.000341	CcSEcCtD
Ibandronate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	1.18e-05	0.00034	CcSEcCtD
Ibandronate—Chills—Estradiol—osteoporosis	1.18e-05	0.00034	CcSEcCtD
Ibandronate—Skin disorder—Zoledronate—osteoporosis	1.18e-05	0.000339	CcSEcCtD
Ibandronate—Pruritus—Calcitriol—osteoporosis	1.17e-05	0.000338	CcSEcCtD
Ibandronate—Hyperhidrosis—Zoledronate—osteoporosis	1.17e-05	0.000337	CcSEcCtD
Ibandronate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	1.17e-05	0.000337	CcSEcCtD
Ibandronate—Diarrhoea—Raloxifene—osteoporosis	1.17e-05	0.000337	CcSEcCtD
Ibandronate—Dyspepsia—Pamidronate—osteoporosis	1.17e-05	0.000336	CcSEcCtD
Ibandronate—Dizziness—Estropipate—osteoporosis	1.17e-05	0.000336	CcSEcCtD
Ibandronate—Anaphylactic shock—Conjugated Estrogens—osteoporosis	1.17e-05	0.000336	CcSEcCtD
Ibandronate—Alopecia—Estradiol—osteoporosis	1.16e-05	0.000334	CcSEcCtD
Ibandronate—Infection—Conjugated Estrogens—osteoporosis	1.16e-05	0.000334	CcSEcCtD
Ibandronate—Decreased appetite—Pamidronate—osteoporosis	1.15e-05	0.000332	CcSEcCtD
Ibandronate—Mental disorder—Estradiol—osteoporosis	1.15e-05	0.000332	CcSEcCtD
Ibandronate—Dizziness—Alendronate—osteoporosis	1.15e-05	0.000331	CcSEcCtD
Ibandronate—Shock—Conjugated Estrogens—osteoporosis	1.15e-05	0.000331	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Pamidronate—osteoporosis	1.15e-05	0.00033	CcSEcCtD
Ibandronate—Nervous system disorder—Conjugated Estrogens—osteoporosis	1.15e-05	0.000329	CcSEcCtD
Ibandronate—Malnutrition—Estradiol—osteoporosis	1.15e-05	0.000329	CcSEcCtD
Ibandronate—Erythema—Estradiol—osteoporosis	1.15e-05	0.000329	CcSEcCtD
Ibandronate—Fatigue—Pamidronate—osteoporosis	1.14e-05	0.000329	CcSEcCtD
Ibandronate—Gastrointestinal pain—Risedronate—osteoporosis	1.14e-05	0.000329	CcSEcCtD
Ibandronate—Urticaria—Ethinyl Estradiol—osteoporosis	1.14e-05	0.000327	CcSEcCtD
Ibandronate—Pain—Pamidronate—osteoporosis	1.14e-05	0.000327	CcSEcCtD
Ibandronate—Constipation—Pamidronate—osteoporosis	1.14e-05	0.000327	CcSEcCtD
Ibandronate—Diarrhoea—Calcitriol—osteoporosis	1.14e-05	0.000327	CcSEcCtD
Ibandronate—Skin disorder—Conjugated Estrogens—osteoporosis	1.13e-05	0.000326	CcSEcCtD
Ibandronate—Abdominal pain—Ethinyl Estradiol—osteoporosis	1.13e-05	0.000326	CcSEcCtD
Ibandronate—Body temperature increased—Ethinyl Estradiol—osteoporosis	1.13e-05	0.000326	CcSEcCtD
Ibandronate—Dizziness—Raloxifene—osteoporosis	1.13e-05	0.000326	CcSEcCtD
Ibandronate—Hyperhidrosis—Conjugated Estrogens—osteoporosis	1.13e-05	0.000325	CcSEcCtD
Ibandronate—Flatulence—Estradiol—osteoporosis	1.13e-05	0.000325	CcSEcCtD
Ibandronate—Vomiting—Estropipate—osteoporosis	1.12e-05	0.000323	CcSEcCtD
Ibandronate—Dysgeusia—Estradiol—osteoporosis	1.12e-05	0.000323	CcSEcCtD
Ibandronate—Rash—Estropipate—osteoporosis	1.11e-05	0.000321	CcSEcCtD
Ibandronate—Dermatitis—Estropipate—osteoporosis	1.11e-05	0.00032	CcSEcCtD
Ibandronate—Urticaria—Risedronate—osteoporosis	1.11e-05	0.000319	CcSEcCtD
Ibandronate—Back pain—Estradiol—osteoporosis	1.11e-05	0.000319	CcSEcCtD
Ibandronate—Headache—Estropipate—osteoporosis	1.11e-05	0.000319	CcSEcCtD
Ibandronate—Vomiting—Alendronate—osteoporosis	1.11e-05	0.000318	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Zoledronate—osteoporosis	1.1e-05	0.000318	CcSEcCtD
Ibandronate—Body temperature increased—Risedronate—osteoporosis	1.1e-05	0.000318	CcSEcCtD
Ibandronate—Abdominal pain—Risedronate—osteoporosis	1.1e-05	0.000318	CcSEcCtD
Ibandronate—Muscle spasms—Estradiol—osteoporosis	1.1e-05	0.000317	CcSEcCtD
Ibandronate—Rash—Alendronate—osteoporosis	1.1e-05	0.000316	CcSEcCtD
Ibandronate—Insomnia—Zoledronate—osteoporosis	1.1e-05	0.000316	CcSEcCtD
Ibandronate—Dermatitis—Alendronate—osteoporosis	1.1e-05	0.000315	CcSEcCtD
Ibandronate—Feeling abnormal—Pamidronate—osteoporosis	1.09e-05	0.000315	CcSEcCtD
Ibandronate—Headache—Alendronate—osteoporosis	1.09e-05	0.000314	CcSEcCtD
Ibandronate—Paraesthesia—Zoledronate—osteoporosis	1.09e-05	0.000313	CcSEcCtD
Ibandronate—Vomiting—Raloxifene—osteoporosis	1.09e-05	0.000313	CcSEcCtD
Ibandronate—Gastrointestinal pain—Pamidronate—osteoporosis	1.09e-05	0.000312	CcSEcCtD
Ibandronate—Rash—Raloxifene—osteoporosis	1.08e-05	0.000311	CcSEcCtD
Ibandronate—Dermatitis—Raloxifene—osteoporosis	1.08e-05	0.00031	CcSEcCtD
Ibandronate—Headache—Raloxifene—osteoporosis	1.07e-05	0.000309	CcSEcCtD
Ibandronate—Dyspepsia—Zoledronate—osteoporosis	1.07e-05	0.000307	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	1.06e-05	0.000306	CcSEcCtD
Ibandronate—Ill-defined disorder—Estradiol—osteoporosis	1.06e-05	0.000306	CcSEcCtD
Ibandronate—Insomnia—Conjugated Estrogens—osteoporosis	1.06e-05	0.000304	CcSEcCtD
Ibandronate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	1.06e-05	0.000304	CcSEcCtD
Ibandronate—Vomiting—Calcitriol—osteoporosis	1.05e-05	0.000303	CcSEcCtD
Ibandronate—Decreased appetite—Zoledronate—osteoporosis	1.05e-05	0.000303	CcSEcCtD
Ibandronate—Nausea—Estropipate—osteoporosis	1.05e-05	0.000302	CcSEcCtD
Ibandronate—Abdominal pain—Pamidronate—osteoporosis	1.05e-05	0.000302	CcSEcCtD
Ibandronate—Body temperature increased—Pamidronate—osteoporosis	1.05e-05	0.000302	CcSEcCtD
Ibandronate—Paraesthesia—Conjugated Estrogens—osteoporosis	1.05e-05	0.000302	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Zoledronate—osteoporosis	1.05e-05	0.000301	CcSEcCtD
Ibandronate—Angioedema—Estradiol—osteoporosis	1.05e-05	0.000301	CcSEcCtD
Ibandronate—Rash—Calcitriol—osteoporosis	1.05e-05	0.000301	CcSEcCtD
Ibandronate—Fatigue—Zoledronate—osteoporosis	1.05e-05	0.000301	CcSEcCtD
Ibandronate—Dermatitis—Calcitriol—osteoporosis	1.05e-05	0.000301	CcSEcCtD
Ibandronate—Headache—Calcitriol—osteoporosis	1.04e-05	0.000299	CcSEcCtD
Ibandronate—Pain—Zoledronate—osteoporosis	1.04e-05	0.000298	CcSEcCtD
Ibandronate—Constipation—Zoledronate—osteoporosis	1.04e-05	0.000298	CcSEcCtD
Ibandronate—Nausea—Alendronate—osteoporosis	1.03e-05	0.000297	CcSEcCtD
Ibandronate—Malaise—Estradiol—osteoporosis	1.03e-05	0.000297	CcSEcCtD
Ibandronate—Hypersensitivity—Risedronate—osteoporosis	1.03e-05	0.000296	CcSEcCtD
Ibandronate—Vertigo—Estradiol—osteoporosis	1.03e-05	0.000296	CcSEcCtD
Ibandronate—Dyspepsia—Conjugated Estrogens—osteoporosis	1.03e-05	0.000296	CcSEcCtD
Ibandronate—Asthenia—Ethinyl Estradiol—osteoporosis	1.03e-05	0.000296	CcSEcCtD
Ibandronate—Nausea—Raloxifene—osteoporosis	1.02e-05	0.000293	CcSEcCtD
Ibandronate—Decreased appetite—Conjugated Estrogens—osteoporosis	1.02e-05	0.000292	CcSEcCtD
Ibandronate—Pruritus—Ethinyl Estradiol—osteoporosis	1.01e-05	0.000292	CcSEcCtD
Ibandronate—Palpitations—Estradiol—osteoporosis	1.01e-05	0.000291	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	1.01e-05	0.00029	CcSEcCtD
Ibandronate—Fatigue—Conjugated Estrogens—osteoporosis	1.01e-05	0.00029	CcSEcCtD
Ibandronate—Asthenia—Risedronate—osteoporosis	1e-05	0.000288	CcSEcCtD
Ibandronate—Feeling abnormal—Zoledronate—osteoporosis	9.99e-06	0.000288	CcSEcCtD
Ibandronate—Constipation—Conjugated Estrogens—osteoporosis	9.99e-06	0.000287	CcSEcCtD
Ibandronate—Pain—Conjugated Estrogens—osteoporosis	9.99e-06	0.000287	CcSEcCtD
Ibandronate—Gastrointestinal pain—Zoledronate—osteoporosis	9.92e-06	0.000285	CcSEcCtD
Ibandronate—Hypertension—Estradiol—osteoporosis	9.89e-06	0.000284	CcSEcCtD
Ibandronate—Pruritus—Risedronate—osteoporosis	9.88e-06	0.000284	CcSEcCtD
Ibandronate—Nausea—Calcitriol—osteoporosis	9.85e-06	0.000283	CcSEcCtD
Ibandronate—Diarrhoea—Ethinyl Estradiol—osteoporosis	9.8e-06	0.000282	CcSEcCtD
Ibandronate—Hypersensitivity—Pamidronate—osteoporosis	9.78e-06	0.000281	CcSEcCtD
Ibandronate—Arthralgia—Estradiol—osteoporosis	9.75e-06	0.00028	CcSEcCtD
Ibandronate—Chest pain—Estradiol—osteoporosis	9.75e-06	0.00028	CcSEcCtD
Ibandronate—Myalgia—Estradiol—osteoporosis	9.75e-06	0.00028	CcSEcCtD
Ibandronate—Anxiety—Estradiol—osteoporosis	9.72e-06	0.00028	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	9.68e-06	0.000279	CcSEcCtD
Ibandronate—Urticaria—Zoledronate—osteoporosis	9.63e-06	0.000277	CcSEcCtD
Ibandronate—Discomfort—Estradiol—osteoporosis	9.63e-06	0.000277	CcSEcCtD
Ibandronate—Abdominal pain—Zoledronate—osteoporosis	9.59e-06	0.000276	CcSEcCtD
Ibandronate—Body temperature increased—Zoledronate—osteoporosis	9.59e-06	0.000276	CcSEcCtD
Ibandronate—Diarrhoea—Risedronate—osteoporosis	9.56e-06	0.000275	CcSEcCtD
Ibandronate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	9.55e-06	0.000275	CcSEcCtD
Ibandronate—Dry mouth—Estradiol—osteoporosis	9.54e-06	0.000274	CcSEcCtD
Ibandronate—Asthenia—Pamidronate—osteoporosis	9.53e-06	0.000274	CcSEcCtD
Ibandronate—Dizziness—Ethinyl Estradiol—osteoporosis	9.47e-06	0.000273	CcSEcCtD
Ibandronate—Pruritus—Pamidronate—osteoporosis	9.39e-06	0.00027	CcSEcCtD
Ibandronate—Anaphylactic shock—Estradiol—osteoporosis	9.35e-06	0.000269	CcSEcCtD
Ibandronate—Infection—Estradiol—osteoporosis	9.29e-06	0.000267	CcSEcCtD
Ibandronate—Urticaria—Conjugated Estrogens—osteoporosis	9.28e-06	0.000267	CcSEcCtD
Ibandronate—Dizziness—Risedronate—osteoporosis	9.24e-06	0.000266	CcSEcCtD
Ibandronate—Abdominal pain—Conjugated Estrogens—osteoporosis	9.23e-06	0.000266	CcSEcCtD
Ibandronate—Body temperature increased—Conjugated Estrogens—osteoporosis	9.23e-06	0.000266	CcSEcCtD
Ibandronate—Shock—Estradiol—osteoporosis	9.2e-06	0.000265	CcSEcCtD
Ibandronate—Nervous system disorder—Estradiol—osteoporosis	9.17e-06	0.000264	CcSEcCtD
Ibandronate—Vomiting—Ethinyl Estradiol—osteoporosis	9.11e-06	0.000262	CcSEcCtD
Ibandronate—Diarrhoea—Pamidronate—osteoporosis	9.08e-06	0.000261	CcSEcCtD
Ibandronate—Skin disorder—Estradiol—osteoporosis	9.08e-06	0.000261	CcSEcCtD
Ibandronate—Hyperhidrosis—Estradiol—osteoporosis	9.04e-06	0.00026	CcSEcCtD
Ibandronate—Rash—Ethinyl Estradiol—osteoporosis	9.03e-06	0.00026	CcSEcCtD
Ibandronate—Dermatitis—Ethinyl Estradiol—osteoporosis	9.02e-06	0.00026	CcSEcCtD
Ibandronate—Headache—Ethinyl Estradiol—osteoporosis	8.97e-06	0.000258	CcSEcCtD
Ibandronate—Hypersensitivity—Zoledronate—osteoporosis	8.94e-06	0.000257	CcSEcCtD
Ibandronate—Vomiting—Risedronate—osteoporosis	8.88e-06	0.000255	CcSEcCtD
Ibandronate—Rash—Risedronate—osteoporosis	8.81e-06	0.000253	CcSEcCtD
Ibandronate—Dermatitis—Risedronate—osteoporosis	8.8e-06	0.000253	CcSEcCtD
Ibandronate—Dizziness—Pamidronate—osteoporosis	8.78e-06	0.000253	CcSEcCtD
Ibandronate—Headache—Risedronate—osteoporosis	8.75e-06	0.000252	CcSEcCtD
Ibandronate—Asthenia—Zoledronate—osteoporosis	8.7e-06	0.00025	CcSEcCtD
Ibandronate—Hypersensitivity—Conjugated Estrogens—osteoporosis	8.6e-06	0.000248	CcSEcCtD
Ibandronate—Pruritus—Zoledronate—osteoporosis	8.58e-06	0.000247	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Estradiol—osteoporosis	8.52e-06	0.000245	CcSEcCtD
Ibandronate—Nausea—Ethinyl Estradiol—osteoporosis	8.51e-06	0.000245	CcSEcCtD
Ibandronate—Insomnia—Estradiol—osteoporosis	8.45e-06	0.000243	CcSEcCtD
Ibandronate—Vomiting—Pamidronate—osteoporosis	8.44e-06	0.000243	CcSEcCtD
Ibandronate—Paraesthesia—Estradiol—osteoporosis	8.39e-06	0.000241	CcSEcCtD
Ibandronate—Asthenia—Conjugated Estrogens—osteoporosis	8.38e-06	0.000241	CcSEcCtD
Ibandronate—Rash—Pamidronate—osteoporosis	8.37e-06	0.000241	CcSEcCtD
Ibandronate—Dermatitis—Pamidronate—osteoporosis	8.36e-06	0.000241	CcSEcCtD
Ibandronate—Headache—Pamidronate—osteoporosis	8.32e-06	0.000239	CcSEcCtD
Ibandronate—Diarrhoea—Zoledronate—osteoporosis	8.3e-06	0.000239	CcSEcCtD
Ibandronate—Nausea—Risedronate—osteoporosis	8.3e-06	0.000239	CcSEcCtD
Ibandronate—Pruritus—Conjugated Estrogens—osteoporosis	8.26e-06	0.000238	CcSEcCtD
Ibandronate—Dyspepsia—Estradiol—osteoporosis	8.23e-06	0.000237	CcSEcCtD
Ibandronate—Decreased appetite—Estradiol—osteoporosis	8.12e-06	0.000234	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Estradiol—osteoporosis	8.07e-06	0.000232	CcSEcCtD
Ibandronate—Fatigue—Estradiol—osteoporosis	8.06e-06	0.000232	CcSEcCtD
Ibandronate—Dizziness—Zoledronate—osteoporosis	8.02e-06	0.000231	CcSEcCtD
Ibandronate—Pain—Estradiol—osteoporosis	7.99e-06	0.00023	CcSEcCtD
Ibandronate—Constipation—Estradiol—osteoporosis	7.99e-06	0.00023	CcSEcCtD
Ibandronate—Diarrhoea—Conjugated Estrogens—osteoporosis	7.99e-06	0.00023	CcSEcCtD
Ibandronate—Nausea—Pamidronate—osteoporosis	7.89e-06	0.000227	CcSEcCtD
Ibandronate—Dizziness—Conjugated Estrogens—osteoporosis	7.72e-06	0.000222	CcSEcCtD
Ibandronate—Vomiting—Zoledronate—osteoporosis	7.71e-06	0.000222	CcSEcCtD
Ibandronate—Feeling abnormal—Estradiol—osteoporosis	7.7e-06	0.000222	CcSEcCtD
Ibandronate—Rash—Zoledronate—osteoporosis	7.65e-06	0.00022	CcSEcCtD
Ibandronate—Gastrointestinal pain—Estradiol—osteoporosis	7.64e-06	0.00022	CcSEcCtD
Ibandronate—Dermatitis—Zoledronate—osteoporosis	7.64e-06	0.00022	CcSEcCtD
Ibandronate—Headache—Zoledronate—osteoporosis	7.6e-06	0.000219	CcSEcCtD
Ibandronate—Vomiting—Conjugated Estrogens—osteoporosis	7.43e-06	0.000214	CcSEcCtD
Ibandronate—Urticaria—Estradiol—osteoporosis	7.43e-06	0.000214	CcSEcCtD
Ibandronate—Body temperature increased—Estradiol—osteoporosis	7.39e-06	0.000213	CcSEcCtD
Ibandronate—Abdominal pain—Estradiol—osteoporosis	7.39e-06	0.000213	CcSEcCtD
Ibandronate—Rash—Conjugated Estrogens—osteoporosis	7.36e-06	0.000212	CcSEcCtD
Ibandronate—Dermatitis—Conjugated Estrogens—osteoporosis	7.36e-06	0.000212	CcSEcCtD
Ibandronate—Headache—Conjugated Estrogens—osteoporosis	7.32e-06	0.00021	CcSEcCtD
Ibandronate—Nausea—Zoledronate—osteoporosis	7.2e-06	0.000207	CcSEcCtD
Ibandronate—Nausea—Conjugated Estrogens—osteoporosis	6.94e-06	0.0002	CcSEcCtD
Ibandronate—Hypersensitivity—Estradiol—osteoporosis	6.89e-06	0.000198	CcSEcCtD
Ibandronate—Asthenia—Estradiol—osteoporosis	6.71e-06	0.000193	CcSEcCtD
Ibandronate—Pruritus—Estradiol—osteoporosis	6.61e-06	0.00019	CcSEcCtD
Ibandronate—Diarrhoea—Estradiol—osteoporosis	6.39e-06	0.000184	CcSEcCtD
Ibandronate—Dizziness—Estradiol—osteoporosis	6.18e-06	0.000178	CcSEcCtD
Ibandronate—Vomiting—Estradiol—osteoporosis	5.94e-06	0.000171	CcSEcCtD
Ibandronate—Rash—Estradiol—osteoporosis	5.89e-06	0.00017	CcSEcCtD
Ibandronate—Dermatitis—Estradiol—osteoporosis	5.89e-06	0.000169	CcSEcCtD
Ibandronate—Headache—Estradiol—osteoporosis	5.86e-06	0.000168	CcSEcCtD
Ibandronate—Nausea—Estradiol—osteoporosis	5.55e-06	0.00016	CcSEcCtD
